Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 18:13:09 GMT 2025
by
admin
on
Tue Apr 01 18:13:09 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
VH92ICR8HX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
VH92ICR8HX
Created by
admin on Tue Apr 01 18:13:09 GMT 2025 , Edited by admin on Tue Apr 01 18:13:09 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_65 | 1_298 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_53 |
| N | 1_318 |
| N | 1_358 |
| N | 1_421 |
| N | 1_422 |
| N | 1_519 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
INHIBITOR -> TARGET |
the Ki of PEAQX revealed it only shows a 5 fold difference in affinity for GluN1/GluN2A vs. GluN1/GluN2B receptors. It is also a potent anticonvulsant in animal tests.
COMPETITIVE ANTAGONIST
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | [1_860] [1_868] [1_907] [1_1003] [1_1037] [1_1040] [1_1176] | DEXFOSFOSERINE | VI4F0K069V |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|